Based on the analysis of its November 2013 meeting, there were no real references to conditions in the economic or pricing sections of the PBAC's Public Summary Documents. At the November 2024 meeting, there were 160. …
The PBAC's 'conditionality' and 'provisional' revolution from 2013 to 2024
August 21, 2025 Latest NewsBioPharma
Latest Video
New Stories
-
The 'Dispatched' Week in Review Podcast - 22 August
August 22, 2025 - - Podcast -
If companies accept conditional recommendations, they will keep imposing them
August 22, 2025 - - Latest News -
Applications now open for AusBiotech Invest and the Early-Stage Innovation Forum
August 21, 2025 - - Australian Biotech -
Seymour welcomes Medsafe's year-on-year approvals improvement
August 21, 2025 - - Latest News -
We don't need new laws for conditional outcomes, because they are already embedded in the system
August 21, 2025 - - Latest News -
Draft NICE guidance proposes major shake-up of UK diabetes treatment
August 21, 2025 - - Latest News -
The PBAC's 'conditionality' and 'provisional' revolution from 2013 to 2024
August 21, 2025 - - Latest News